Results 251 to 260 of about 98,136 (348)
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study. [PDF]
Clin EpigeneticsDubath C +10 more
europepmc +1 more source
Effects of Psychotropic Drugs on the Development of Activity-Stress Ulcer in Rats
, 1984 Chiaki Hara, Nobuya Ogawa
openalex +1 more source
British Journal of Pharmacology, EarlyView.Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt +3 more
wiley +1 more source
Cross-physical dependence liability of psychotropic drugs in rats dependent on barbiturates.
, 1983 Eijiro Tagashira +3 more
openalex +1 more source
Psilocybin as a novel treatment for chronic pain
British Journal of Pharmacology, EarlyView.Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey +3 more
wiley +1 more source
British Journal of Pharmacology, EarlyView.Abstract Background and Purpose Opioid use disorder (OUD) is a pressing public health concern marked by frequent relapse during periods of abstinence, perpetuated by negative affective states. Classical antidepressants or the currently prescribed opioid pharmacotherapies have limited efficacy to reverse the negative affect or prevent relapse ...
Andria Michael +7 more
wiley +1 more source